Do GLP-1 Analogs Have a Place in the Treatment of PCOS? New Insights and Promising Therapies

Polycystic ovary syndrome (PCOS) is the most prevalent endocrinopathy in women of reproductive age. This condition is characterized by hyperandrogenism and either oligo- or anovulation. PCOS patients often present comorbidities such as obesity, insulin resistance, impaired glucose metabolism, dyslip...

Descripción completa

Detalles Bibliográficos
Autores principales: Szczesnowicz, Aleksandra, Szeliga, Anna, Niwczyk, Olga, Bala, Gregory, Meczekalski, Blazej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532286/
https://www.ncbi.nlm.nih.gov/pubmed/37762856
http://dx.doi.org/10.3390/jcm12185915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532286/
https://www.ncbi.nlm.nih.gov/pubmed/37762856
http://dx.doi.org/10.3390/jcm12185915

Ejemplares similares